Attributable fraction: example, cancers due to occupation in the US. Kyle Steenland. Rollins School Public Health Emory University, Atlanta, Ga

Similar documents
The Burden of Occupational Lung Cancer Paul A. Demers, PhD

Occupational carcinogens

The global burden of asbestos-related disease - occupational exposures

Large exposure measurement databases: experiences from CAREX Canada

Update of the scientific evidence on asbestos and cancer. Kurt Straif, MD MPH PhD. The IARC Monographs

Cancer and the Environment: Challenges for Prevention

Asbestos related cancers

Review of Eliminating occupational cancer in Europe and globally by J. Takala

Summary of Investigation into the Occurrence of Cancer Census Tract 2104 Zip Code 77009, Houston Harris County, Texas May 11, 2010

How To Know If You Have Cancer From Work

The Global Burden of Disease Due to Occupational Carcinogens

Asbestos and Cancer in Ontario and The Occupational Cancer Research Centre

NIOSH Publishes Study of Cancer Among Firefighters Claire Reiss National League of Cities Risk Information Sharing Consortium.

Table of Contents. I. Executive Summary A. Summary of our Findings II. Background III. Methodology IV. Key Data Sources...

Adjuvant Therapy Non Small Cell Lung Cancer. Sunil Nagpal MD Director, Thoracic Oncology Jan 30, 2015

Prostate cancer statistics

Statistical Report on Health

AUSTRALIAN VIETNAM VETERANS Mortality and Cancer Incidence Studies. Overarching Executive Summary

Asbestos related cancers

Testimony of. Dr. James Crapo. April 26, 2005

Epidemiological insight into occupational causes of respiratory cancers

Workers compensation claims paid in Australia Occupational exposures to carcinogens in Australia

Skin Cancer: The Facts. Slide content provided by Loraine Marrett, Senior Epidemiologist, Division of Preventive Oncology, Cancer Care Ontario.

Occupational Disease Fatalities Accepted by the Workers Compensation Board

Carcinogens in the Construction Industry

Number. Source: Vital Records, M CDPH

Investigating Community Cancer Concerns--Deer Park Community Advisory Council, 2008

Collection and Use of Industry and Occupation Data III: Cancer surveillance findings among construction workers

Adverse Health Effects of Air Pollution in India

Butler Memorial Hospital Community Health Needs Assessment 2013

Work-Related Disease in New Zealand

Occupational Disease Fatalities Accepted by the Workers Compensation Board

Selected Health Status Indicators DALLAS COUNTY. Jointly produced to assist those seeking to improve health care in rural Alabama

Figure 3.1 Rate of fatal work-related injuries per 100,000 workers, Colorado and the United States,

Leukemia and Exposure to Ionizing Radiation

FINJEM: strenghts and uses in

American Osteopathic College of Occupational and Preventive Medicine 2012 Mid-Year Educational Conference St. Petersburg, Florida

Estimates of work-related cancers in workers exposed to carcinogens

2012 Georgia Occupational Health Indicators: Demographics and Summary Tables

Occupational Disease Fatalities Accepted by the Workers Compensation Board

Cancer Presumption Claims The Law and Science Behind Presumptive Cancer Claims and Rebutting the Same

Studies and Research Projects

Mesothelioma Trends as Predictors of the Asbestos- Related Lung Cancer Burden

Elimination of Asbestos- Related Diseases WHO action. Dr Ivan D. Ivanov Public Health and Environment WHO Headquarters

Smoking and Lung Cancer

Health effects of particulate matter and implications for policy in Europe

RADIATION AND HEALTH NOVEMBER 1996

Likelihood of Cancer

Q&A on Monographs Volume 116: Coffee, maté, and very hot beverages

information CIRCULAR Coronary heart disease in Queensland Michael Coory, Health Information Centre, Information & Business Management Branch Summary

Incorrect Analyses of Radiation and Mesothelioma in the U.S. Transuranium and Uranium Registries Joey Zhou, Ph.D.

The Public Health Management of Chemical Incidents Case Study

OCCUPATIONAL LUNG CANCER

Community Information Book Update October Social and Demographic Characteristics

Chapter 7: Effect Modification

Indicator 3: Fatal Work-Related Injuries

Health effects of occupational exposure to asbestos dust

evaluation of cancer hazards Robert A Baan PhD The IARC MONOGRAPHS International Agency for Research on Cancer Lyon, France

Cancer in Ireland 2013: Annual report of the National Cancer Registry

Estimation of the Number of Lung Cancer Cases Attributable to Asbestos Exposure

STATEMENT ON ESTIMATING THE MORTALITY BURDEN OF PARTICULATE AIR POLLUTION AT THE LOCAL LEVEL

Chemicals, Cancer, and You

Emerging evidence that the ban on asbestos use is reducing the occurrence of pleural mesothelioma in Sweden

Populations of Color in Minnesota

Energy Employees Occupational Illness Compensation Program (EEOICPA)

Q&A on the carcinogenicity of the consumption of red meat and processed meat

Australasian Faculty of Occupational Medicine. Occupational Cancer. A guide to prevention, assessment and investigation

Opportunities for advancing biomarkers for patient stratification and early diagnosis in liver disease

Defending the Rest Basics on Lung Cancer, Other Cancers and Asbestosis: Review of the B-Read and Pulmonary Function Testing

The effect of the introduction of ICD-10 on cancer mortality trends in England and Wales

Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers

Changing Trends in Mesothelioma Incidence. Hans Weill, M.D. Professor of Medicine Emeritus Tulane University Medical Center

Indices of Morbidity and Mortality. Sukon Kanchanaraksa, PhD Johns Hopkins University

Occupational Disease Fatalities Accepted by the Workers Compensation Board

Review of estimates of the global burden of injury and illness due to occupational exposures

Occupational Lung Diseases

Leanne M Poulos Patricia K Correll Brett G Toelle Helen K Reddel Guy B Marks Woolcock Institute of Medical Research, University of Sydney, NSW

Safe Work Australia Research agenda and activities. November 2015

Occupational Heath and Safety Section American Public Health Association

PATTERNS OF MORTALITY IN ASBESTOS FACTORY WORKERS IN LONDON*

Challenges in assessing disease latency for cancer in environmental epidemiology

Science-Based Facts Relevant Health Issues For environmental occupational health safe and responsible use

Chapter I Overview Chapter Contents

An Application of the G-formula to Asbestos and Lung Cancer. Stephen R. Cole. Epidemiology, UNC Chapel Hill. Slides:

Gen Re Dread Disease Survey Initial Results

The asbestos crisis Why Britain needs an eradication law

Biostatistics and Epidemiology within the Paradigm of Public Health. Sukon Kanchanaraksa, PhD Marie Diener-West, PhD Johns Hopkins University

Prevent what is preventable, cure what is curable, provide palliative care for patients in need, and monitor and manage for results.

Limited Pay Policy (L-222B) - Underwriting Guidelines

Singapore Cancer Registry Annual Registry Report Trends in Cancer Incidence in Singapore National Registry of Diseases Office (NRDO)

OCCUPATIONAL CANCER IN AUSTRALIA APRIL 2006

RR833. The joint effect of asbestos exposure and smoking on the risk of lung cancer mortality for asbestos workers ( )

Irish Wolfhound Pedigree Breed Health Survey

Exercise Answers. Exercise B 2. C 3. A 4. B 5. A

Alabama s Rural and Urban Counties

Scientific Update on Safe Use of Asbestos. Robert P. Nolan, PhD International Environmental Research Foundation New York, New York

Section 8» Incidence, Mortality, Survival and Prevalence

Projection of health care expenditure by disease: a case study from Australia

How To Pay For Critical Illness Insurance From The Ihc Group

Lung Cancer and Exposure to Ionizing Radiation

Transcription:

Attributable fraction: example, cancers due to occupation in the US Kyle Steenland Rollins School Public Health Emory University, Atlanta, Ga

Definition The population attributable fraction (AF) estimates the proportion of cases (or deaths) from a disease which could be avoided if exposure were eliminated. The AF is calculated using the relative risk from exposure (risk of disease for the exposed divided by risk for the non exposed) and population prevalence of an exposure (proportion exposed). AFs can then help to inform public health intervention

Here I will present 1) methods and issues in calculating the AF 2) A specific example, the AF for occupational cancer from US* *Another good example of AFs for occupational cancer in England (Rushton et al 2010, which estimated 5.2% of cancer deaths attributable to past exposure).

There are two ways to calculate the AF. One requires access to the raw data from a study (or studies) which generates the RR and the prevalence of exposure. The calculated AF strictly pertains only to that study population, although it is often used for other populations. The other AF more common can be calculated using one RR or many RRs from the literature, without access to the raw data and also estimates of exposure prevalence from the literature. We will focus on that measure, although it is not as clean as the first measure and can be somewhat inaccurate.

AF = (R R0)/R (1) where R is the risk of disease, and Ro is the risk of disease in nonexposed only. This is the proportion of the overall risk of disease due to exposure, which is equivalent to the proportion of cases which occur due to exposure. Formula 1 can be rewritten AF = p(rr 1) / 1 + p (RR 1) (2) Where p is the proportion of the population exposed, and RR is the relative risk of disease (risk in exposed/risk in nonexposed, or R1/Ro)*. *This expression is derived by substituting R =p(r1) + (1 p)(ro) into (1), dividing by R0 to get RRs.

case not case total exp 50 450 500 Not exp 50 1450 1500 100 1900 2000 Example RR= 50/500 / 50/1500=3 AF formula 2=[(500/1500)(3-1)]/[(500/1500)(3-1)+1] = 0.40 40% of disease in this study is attributable to exposure. That means that 40 out of 100 cases would not occur if exposure were eliminated.

Using formula 2, we need only to agree on what the RR for a given exposure is, and what the prevalence of exposure is in the population of interest (eg Canada). However, a number of issues arise which must be decided along the way.

Suppose we want the all cancers combined AF Cancer is not one disease, but many To get the all cancers combined AF in practice we 1) calculate the AF for specific cancers 2) use the AF and the total number of cancer cases to determine the number of cases which would be avoided if exposure were eliminated, for each cancer 3) add the avoidable cases together across all cancers 4) divide the avoidable cases by total cancer cases to get all cancer AF

Which cancer causing exposures (occupational carcinogens) should be included (this in turn decides which cancers)? In our US work included all occupational exposures that IARC determined were class 1 human carcinogens (definite). We also included one class 2A (probable) carcinogen (diesel fumes) Rushton et al. in their recent work in England included all class 1 and class 2A IARC carcinogens, more than we did. This is the main reason they had a higher estimate of the occupational cancer AF in England than we did in the US (5.3% vs 3.6% cancers due to occupational exposures). For example, we did not include shift work and breast cancer (class 2A); this IARC classification had not yet been made when we did our estimate for the US

Where do we get the RRs? We take the RRs from the scientific literature. Sometimes there is one good study giving the RR. Sometimes there are many good studies and we take some kind of average RR from these studies (eg, via a meta analysis). Or we can use the range of RRs and report a range of AFs Example, an average RR for lung cancer for workers exposed to asbestos across many studies might be 2.0

Where do we get the proportion exposed? We may have an estimate of the proportion of the general population currently exposed to a given carcinogen eg, asbestos. This proportion, however, does not take into account past exposure. We want to include workers who are alive today and at risk of cancer from a previous occupational exposure. In our work in the US we had an estimate of the proportion of workers exposed to many workplace toxins in the 1980s from NIOSH, but we wanted to estimate the AF for the US population in 1997.

Where do we get the proportion exposed? We assumed 1) The proportion exposed in the 1980s was similar in the previous years 2) A 40 year latency (risk) period, so that workers exposed from 1957 1997 were of interest 3) There was a 10% occupational turnover yearly over 40 years, and a 10% loss for mortality over that time 4) We multiplied the estimate from the 1980s by 4 to estimate the proportion of the US 1997 population with past exposure

Multiple carcinogenic exposures for the same cancer? Many agents cause lung cancer, such as asbestos, nickel, cadmium, chromium VI, etc. Assuming little overlap (exposed to one but not another), the AF for multiple agents can be calculated by calculating the AF for each one and then combining them by AFall= 1 (1 AF1)(1 AF2)(1 AF3) If the AFs are all small, simply adding them together will get about the same answer, eg, 5%, 5%, 5% AFall = 1 (.95)(.95)(.95)=.143, about the same as.05+.05+.05=.15

Does exposure level matter? Many AFs are calculated for exposed vs non exposed. However, it would be better if one had RRs for high exposure and the proportion highly exposed to derive an AF, and a second RR for low exposure and a proportion exposed to low levels, to calculate a 2 nd AF for low exposure. Typically, the RR will be higher for higher exposure, but the proportion exposed will be lower for high exposures. Often however we do not have sufficient data to calculate separate AFs by exposure level; often the proportions exposed to high levels (defined how?) vs low levels are not available..

Mortality vs morbidity? AFs are equally valid for cancer incidence data or cancer mortality data, if you can assume that the RRs for cancer mortality are the same for cancer morbidity. This is generally a reasonable assumption. Most RRs from the literature are for cancer mortality, but a good number also exist for cancer incidence. If you have good national cancer incidence data, it will be worthwhile to calculate the number of incident cancers due to current and past occupational exposures, as well as the numbers of cancer deaths due to occupational exposure.

YLLs and DALYs? It is possible to consider the burden due to occupational cancer not only in the number of avoidable deaths, or the number of avoidable cases, but also in terms of years of life lost (YLLs) for mortality, or disability life years (DALYs) after cancer incidence (ie, morbidity).

YLLs Assume the average age of death from lung cancer is 70, and the average life expectancy is 80. Assume there are 50,000 lung cancer deaths per year. That means that are 500,000 YLLs for lung cancer. To determine the proportion of YLLs due to occupational carcinogens causing lung cancer, multiply the YLLs by the AF for lung cancer (eg 10%). This would mean that 50,000 years of life are lost each year due to past exposure to occupational carcinogens. YLLs can account for the different impact on premature mortality of different diseases.

DALYs = YLLs +YLDs, accounting for loss due to both premature mortality and disability after disease incidence YLDs are years of live lived with disability DALYs are more controversial, because they are based on a subjective weight given to measure the disability due to living with a given disease. More disability=higher weight. WHO assigns a weight of 0.81 to each year lived with a late stage cancer, 0.15 for an early stage lung cancer, 0.9 for an early stage bladder cancer. Compared to 0.64 for a year lived with Alzheimer s, or 0.50 for a year with AIDs. Then YLD = (annual incident cases*weight*mean duration disease)

Past or future? AFs and number of avoidable cancer deaths refer to past exposures and current burden. If may be worth considering future burden, which means considering exposures today and likely exposures in the future. In many cases the classic carcinogens have been greatly reduced in the workplace, but other new exposures may be widespread and carcinogen. In particular shift work and breast cancer is a potentially important new early stage bladder cancer. It may also be useful to estimate the cost of future occupational cancers vs. the cost of prevention

US example We used mortality data only We did not calculate YLLs or YLDs or DALYs We used only class 1 IARC carcinogens, except diesel fumes (conservative) We calculated only one AF per carcinogen, ignoring exposure level We calculated AFs and number of avoidable deaths for all work related causes, not just cancer

Exposure data When using RRs from cohort studies, we used estimates of the worker population exposed taken from a NIOSH surveys in the early 1980s (NOES) of 4500 workplaces, representing about one third of employed civilians. In some instances, when RRs came from US case control studies representative of the US, the proportion exposed was taken from the controls in that study (or studies).

RRs RRs were taken almost exclusively from US studies. We used a range of RRs rather than calculating a midpoint or average RR. If only a single study was available we used the 95% CI as the range.

Calculation of AFs In many cases we calculated the AFs ourselves, but in other cases we used a range of AFs calculated in the literature, if we thought they were adequate.

Cancer Exposure % exposed RRs Lung Asbestos+ from literature AFs from lit chemicals* Lung ETS at work, nonsmokers 20% of nonsmokers 1.3 Lung Indoor radon at work used estimate # ca s due to indoor radon in homes, and ratio of dose home/work (5 to 1) Bladder Aromatic amine dyes from literature Mesothelioma Asbestos n.a., used % of meso deaths (85 90% male, 23 90% female) n.a. AFs from lit n.a., used % meso deaths Leukemia Benzene, ETO, ionizing 0.07%, 0.04%, 0.05% 2 4, 1.1 3,.5, 1.3 2.1, 1.1 1.4 radiation laryngeal Sulfuric acid+mineral oils 4.4%, 6.4% (males) 1.1 5.0, 1.1 2.0 Non melon. skin cancer Sinonasal+ Nasopharynx PAHs, arsenic 12%, 0.4% (males) 1.1 1.5, 2 Wood dust, nickel, chromium VI 6.8%, 6.0%, 5.2% (males) 3.1, 2,2, 5.2 10.8 Kidney cancer Coke production 0.8% 2 Liver cancer Vinyl chloride 0.5% (males) 2.5 *Arsenic, beryllium, cadmium, chromium, diesel fumes, nickel, silica

Cancer Exposure AF Number deaths annually Lung Lung Asbestos+ chemicals* ETS at work, nonsmokers 6 17% male, 2% females 91,000 male, 62,000 female 1% 15,300 (10% all lung deaths) Lung Indoor radon at work 1% 153,000 2,000 Bladder Aromatic amine dyes 7% 10% male, % 19% female Attributable deaths annually 9,700 19,900 870 7600 male, 3900 female 650 2,100 Mesothelioma Asbestos 85 90% male, 23 2100 male, 500 females 1,900 2,400 90% female Leukemia Benzene, ETO, ionizing radiation 1 3% 19,000 200 500 laryngeal Non melon. skin cancer Sinonasal+ Nasopharynx Sulfuric acid+mineral oils 1 5% 3000 100 600 PAHs, arsenic 1 2% 1400 <100 Wood dust, nickel, chromium VI 30% 40% 300 200 300 Kidney cancer Coke production 1 2% 7200 100 Liver cancer Vinyl chloride 1% 7200 <100 All combined 12,000 26,000 (midpoint 19,000, 3.6%) *Arsenic, beryllium, cadmium, chromium, diesel fumes, nickel, silica

Sources of underestimation Exposures/cancers not included (other IARC class 2A carcinogens) Contributory causes of death not included (cancer may not be the underlying cause we considered only underlying cause) Limited exposure data *unknown workplace carcinogens * did not include generic exposures (eg, painting/lung ca)

Sources of overestimation Inadequate adjustment for confounding factors (some RRs overestimated) Assumed independence of multiple exposures (could be synergistic) RRs too high because based on historically high exposures (recent exposures lower)

Conclusion Our best estimate of cancer deaths attributable to occupational carcinogens in 1997 was 19,000. Our best estimate of all deaths attributable to all occupational hazards was 55,200 (49,000 due to disease, 6,200 due to injury). Cancer accounted for 39% of occupational disease fatalities.

Leading US causes of death 1997 Number deaths Acute myocardial infarction 206,212 lung cancer 151,464 Coronary atherosclerosis 129,649 COPD, not specified 81,893 Pneumonia) 75,815 All deaths due to occupational exposure 55,200 Diabetes 46,328 Colon cancer 45,462 Congestive heart failure 45,419 Breast cancer 41,940 Motor vehicle crash 37,324 Prostate cancer 32,891 Suicide 30,505 Pancreas cancer 27,193 Alzheimer's disease 22,475 lymphomas 22,354 stroke 20,998 homicide 19,491 Occupational cancers 19,000 Emphysema 17,518 Renal failure, unspecified) 13,733

Selected References Driscoll et al., The global burden of disease due to occupational carcinogens, Am J Ind Med 2005; 48: 419 431 Fritschi and Driscoll, Cancer due to occupation in Australia, Aust N Z J Public Health 2006;30:213 9 Nurminen and Karjalainen, Epidemiologic estimate of the proportion of fatalities related to occupational factors in Finland, Scan J Wk Env Hlth 2001; 27: 161 213 Rushton et al, Occupation and Cancer in Britain, Brit J Can 2010; 102: 1428 1437 Steenland et al., Dying for Work: the magnitude of US mortality for selected causes of death associated with occupation, Am J Ind Med 2003: 43: 461 482 Steenland and Armstrong, An overview of methods for calculating the burden of disease due to specific risk factors, Epidemiol 2006; 17: 512 519